Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart Montgomery

Showing results (1-10 of 113) with videos related to

Pageof 12
Sort By:
CNS Spectrums|July 16, 2016
Are the ICD-10 or DSM-5 diagnostic systems able to define those who will benefit from treatment for depression?Stuart Montgomery
International Journal of Psychiatry in Clinical Practice|June 13, 2014
Serotonin noradrenaline reuptake inhibitors: Logical evolution of antidepressant developmentStuart Montgomery
International Clinical Psychopharmacology|March 1, 2018
Mineralocorticoid receptor-related markers and outcome of major depression: focus on blood pressure and electrolytesHarald Murck, Michael Ploch, Stuart Montgomery
The International Journal of Neuropsychopharmacology|September 30, 2010
Efficacy of escitalopram compared to citalopram: a meta-analysisStuart Montgomery, Thomas Hansen, Siegfried Kasper
Pharmacoeconomics|March 8, 2005
Evaluation of the cost effectiveness of escitalopram versus venlafaxine XR in major depressive disorderJosé-Luis Fernandez, Stuart Montgomery, Clément Francois
Current Medical Research and Opinion|July 2, 2013
Long-term treatment of anxiety disorders with pregabalin: a 1 year open-label study of safety and tolerabilityStuart Montgomery, Birol Emir, Hannah Haswell, et al.
Current Medical Research and Opinion|February 5, 2015
Comparison of vortioxetine versus venlafaxine XR in adults in Asia with major depressive disorder: a randomized, double-blind studyGang Wang, Mette Gislum, Gleb Filippov, et al.
International Clinical Psychopharmacology|July 21, 2017
Cariprazine specificity profile in the treatment of acute schizophrenia: a meta-analysis and meta-regression of randomized-controlled trialsFilippo Corponi, Alessandro Serretti, Stuart Montgomery, et al.
Journal of Clinical Psychopharmacology|January 25, 2003
The antidepressant efficacy of reboxetine in patients with severe depressionStuart Montgomery, James M Ferguson, Gerri E Schwartz
Molecular Biology of the Cell|February 21, 2002
Essential role of MCM proteins in premeiotic DNA replicationKarola Lindner, Juraj Gregán, Stuart Montgomery, et al.
Pageof 12

Showing results (1-10 of 113) with videos related to

Sort By:
Pageof 12
CNS Spectrums|July 16, 2016
Are the ICD-10 or DSM-5 diagnostic systems able to define those who will benefit from treatment for depression?Stuart Montgomery
International Journal of Psychiatry in Clinical Practice|June 13, 2014
Serotonin noradrenaline reuptake inhibitors: Logical evolution of antidepressant developmentStuart Montgomery
International Clinical Psychopharmacology|March 1, 2018
Mineralocorticoid receptor-related markers and outcome of major depression: focus on blood pressure and electrolytesHarald Murck, Michael Ploch, Stuart Montgomery
The International Journal of Neuropsychopharmacology|September 30, 2010
Efficacy of escitalopram compared to citalopram: a meta-analysisStuart Montgomery, Thomas Hansen, Siegfried Kasper
Pharmacoeconomics|March 8, 2005
Evaluation of the cost effectiveness of escitalopram versus venlafaxine XR in major depressive disorderJosé-Luis Fernandez, Stuart Montgomery, Clément Francois
Current Medical Research and Opinion|July 2, 2013
Long-term treatment of anxiety disorders with pregabalin: a 1 year open-label study of safety and tolerabilityStuart Montgomery, Birol Emir, Hannah Haswell, et al.
Current Medical Research and Opinion|February 5, 2015
Comparison of vortioxetine versus venlafaxine XR in adults in Asia with major depressive disorder: a randomized, double-blind studyGang Wang, Mette Gislum, Gleb Filippov, et al.
International Clinical Psychopharmacology|July 21, 2017
Cariprazine specificity profile in the treatment of acute schizophrenia: a meta-analysis and meta-regression of randomized-controlled trialsFilippo Corponi, Alessandro Serretti, Stuart Montgomery, et al.
Journal of Clinical Psychopharmacology|January 25, 2003
The antidepressant efficacy of reboxetine in patients with severe depressionStuart Montgomery, James M Ferguson, Gerri E Schwartz
Molecular Biology of the Cell|February 21, 2002
Essential role of MCM proteins in premeiotic DNA replicationKarola Lindner, Juraj Gregán, Stuart Montgomery, et al.
Pageof 12